2001
DOI: 10.1002/1097-0347(200102)23:2<113::aid-hed1006>3.0.co;2-w
|View full text |Cite
|
Sign up to set email alerts
|

Health-related quality of life three years after diagnosis of head and neck cancer?A longitudinal study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

21
269
3
21

Year Published

2004
2004
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 325 publications
(323 citation statements)
references
References 31 publications
21
269
3
21
Order By: Relevance
“…Since these two assessments are in the proximity of the onset of the cancer, it is likely that a decrease in QoL in these phases is directly related to the consequence of cancer and the side effects of the treatments, while in the long time (12 months after the diagnosis) the negative effects are generally alleviated by beneficial consequences of treatments and intervention [50][51][52]. Deterioration was calculated by subtracting the value reported at the premorbid measurement from the lowest value of the corresponding variable.…”
Section: Adaptationmentioning
confidence: 99%
“…Since these two assessments are in the proximity of the onset of the cancer, it is likely that a decrease in QoL in these phases is directly related to the consequence of cancer and the side effects of the treatments, while in the long time (12 months after the diagnosis) the negative effects are generally alleviated by beneficial consequences of treatments and intervention [50][51][52]. Deterioration was calculated by subtracting the value reported at the premorbid measurement from the lowest value of the corresponding variable.…”
Section: Adaptationmentioning
confidence: 99%
“…The EORTC QLQ-H&N35 is widely used to measure quality of life in H&N cancer patients (Singer et al, 2013). Both prospective and cross-sectional studies (Bjordal et al, 2001;Hammerlid et al, 2001aHammerlid et al, , 2001bHammerlid et al, , 2001cNguyen et al, 2002;Talmi et al, 2002;Shepherd and Fisher, 2004) have documented reductions in HRQOL in populations of H&N cancer patients who have received RT. Several studies have also examined changes in HRQOL during the treatment period (Bjordal et al, 2001;Henson et al, 2001; Airolldi et al, 2004;Parliament et al, 2004;Jabbari et al, 2005; Braam et al, 2007; Curran et al, 2007; Ackerstaff et al, 2009; Ackerstaff et al, 2012;Maguire et al, 2011;Maurer et al, 2011;Nutting et al, 2011).…”
mentioning
confidence: 99%
“…19 In our study we found that frequency of MDD was 40% which was consistent with previous studies. 1,[5][6][7][8][9][10][11][12][13] In comparison to normal population, higher rates of depression was found in this study because patients were chosen from oncology outpatient department of tertiary care hospital which is the highest source of patients with oral cancer. Among 28 patients of MDD, 19 patients (48.72%) were from advanced stage of cancer and 20 patients (71.42%) were labourer.…”
Section: Discussionmentioning
confidence: 72%
“…2 The incidence of depression in HNC patients ranges between 15% and 50%. [3][4][5][6][7][8][9][10][11] Important issue in HNC is depression: major depressive disorder (MDD) has been reported in up to 40% of patients with HNC, typically within the first 3 months of diagnosis. 12 The incidence of HNC is relatively low in developed countries and highest in South East Asia.…”
Section: Introductionmentioning
confidence: 99%